The Russia-based cybersecurity software producer, which launched an accelerator last year, will invest up to $1m in strategically relevant startups.

The immuno-oncology drug developer, backed by several pharmaceutical firms, has raised $55m in an IPO that saw it float substantially below its $14 to $16 range.

Researchers at Cambridge University have created the first nano-engine and are now hoping to commercialise the technology.

The venture capital firm, in which Otto Group is a major investor, will operate the fund together with a $290m growth-stage fund.

Stanmore Implants is acquired by Stryker Corporation, providing an exit to Imperial Innovations.

Caterpillar's corporate venturing unit has committed capital to the latest fund to be raised by Emerald Technology Ventures, with due diligence being carried out on other potential investors.

Oxford University big data spinout Zegami launches its global expansion efforts, despite only being a few months old.

Mercia Fund Management backs Bristol University spinout Pertinax Pharma as it begins to scale up the production of its chlorhexidine-based product.